Back to User profile » Prof. Dr. Shukui Qin

Papers published by Prof. Dr. Shukui Qin:

Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer

Qin S, Xu RH, Shen L, Xu J, Bai Y, Yang L, Deng Y, Chen ZD, Zhong H, Pan H, Guo W, Shu Y, Yuan Y, Zhou J, Xu N, Liu T, Ma D, Wu C, Cheng Y, Chen D, Li W, Sun S, Yu Z, Cao P, Chen H, Wang J, Wang S, Wang H, Wang N, Zhang B, Zhang Q, Su W, Guo X, Li J

OncoTargets and Therapy 2021, 14:4439-4450

Published Date: 11 August 2021

Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study

Li H, Qin S, Liu Y, Chen Z, Ren Z, Xiong J, Meng Z, Zhang X, Wang L, Zhang X, Zou J

Drug Design, Development and Therapy 2021, 15:1873-1882

Published Date: 3 May 2021

A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix

Chen C, Qin S, Li Z, Luo X, Zhang Y, Zhang J, Liu X

OncoTargets and Therapy 2019, 12:5805-5811

Published Date: 17 July 2019

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung

Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L

OncoTargets and Therapy 2018, 11:8565-8573

Published Date: 30 November 2018

Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report

Cheng Y, Zhang J, Qin SK, Hua HQ

OncoTargets and Therapy 2018, 11:5957-5962

Published Date: 18 September 2018